A Living-Subject Cannabis Blood-Fraction Ratio Did Not Validate Postmortem Conversion

A plasma-to-whole-blood relationship observed in living cannabis users did not validate the same conversion after death. Giroud and colleagues found substantially greater variability in postmortem samples and cautioned against applying an exposure-time model in that setting.

The study compared different blood fractions

The investigators examined cannabinoid measurements in eight living regular cannabis users and six deceased people. The living comparison involved plasma and whole blood; the postmortem comparison involved the separated fraction described as serum and whole blood.

Among living subjects, ratios were more consistent within individuals, and the authors discussed an approximate factor of 1.6. Postmortem ratios were more scattered, with a reported mean around 2.4. These are study summaries, not exact conversion constants for an individual specimen.

Conversion and model validity are separate

Even if a blood-fraction ratio were estimated accurately, that would not establish that an exposure-time model remained valid in a different biological setting. Changing the input’s units or matrix does not recreate the conditions under which a model was developed.

The authors did not recommend applying the Huestis exposure-time model to postmortem specimens. Their caution should not be replaced by multiplying a whole-blood result by the postmortem group mean and treating the resulting estimate as validated.

Document the specimen before calculating

A case interpretation should identify whether the laboratory tested whole blood, plasma or serum, and whether the sample was collected before or after death. Those details belong alongside any concentration.

The study was small, and the observed variability limits precision. Its findings support careful specimen-specific interpretation; they do not establish a universal postmortem correction or convert cannabinoid exposure into proof of impairment at an earlier event.

Related: Why the blood fraction matters for THC interpretation.

Research cited

Giroud C; Menetrey A; Augsburger M; et al.; Forensic Science International; 2001. Delta-9-THC, 11-OH-Delta-9-THC and Delta-9-THCCOOH plasma or serum to whole blood concentrations distribution ratios in blood samples taken from living and dead people.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A Living-Subject Cannabis Blood-Fraction Ratio Did Not Validate Postmortem Conversion

A plasma-to-whole-blood relationship observed in living cannabis users did not validate the same conversion after death. Giroud and colleagues found substantially greater variability in postmortem samples and cautioned against applying an exposure-time model in that setting. The study compared different blood fractions The investigators examined cannabinoid measurements in eight living…

Spread the love

Read Article: A Living-Subject Cannabis Blood-Fraction Ratio Did Not Validate Postmortem Conversion

A Cannabis Muscle-Tone Opinion Needs a Defined Measurement Method

A statement that someone’s muscle tone indicates cannabis impairment needs a defined observation and measurement method. A published perspective questions whether a subjective limb assessment can carry the same meaning as a standardized clinical evaluation. The critique concerns what was measured The perspective contrasts descriptions such as normal, rigid or…

Spread the love

Read Article: A Cannabis Muscle-Tone Opinion Needs a Defined Measurement Method

A THC-Positive Driver Case Series Did Not Supply a Drug-Free Specificity Group

A study selected from THC-positive driver investigations cannot establish drug-free specificity without a suitable negative comparison group. A two-year case review provides useful observations within its selected cases, but it does not answer every diagnostic-accuracy question. Selection happened before the final analysis Declues and colleagues began with THC-positive cases from…

Spread the love

Read Article: A THC-Positive Driver Case Series Did Not Supply a Drug-Free Specificity Group

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us